Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Wiener Medizinische Wochenschrift (1946)|April 6, 2012
Basic principles of molecular effects of irradiationEdgar Selzer, Alexandra HebarExpert Review of Clinical Pharmacology|January 1, 2013
The impact of molecular targets in cancer drug development: major hurdles and future strategiesAlexandra Hebar, Peter Valent, Edgar SelzerPlos One|October 3, 2012
NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent mannerAlexandra Hebar, Barbara C Rütgen, Edgar SelzerPlos One|October 17, 2012
The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer riskKatharina Proestling, Alexandra Hebar, Nina Pruckner, et al.Basic & Clinical Pharmacology & Toxicology|April 22, 2010
Pre-clinical safety evaluation of pyrrolidine dithiocarbamateMonika Chabicovsky, Eva Prieschl-Grassauer, Joachim Seipelt, et al.Plos One|April 16, 2015
Non-clinical safety evaluation of intranasal iota-carrageenanAlexandra Hebar, Christiane Koller, Jan-Marcus Seifert, et al.American Journal of Cancer Research|May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cellsThomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.Pageof 1